Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-09-11
1997-03-25
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 255, 536 256, A61K 3170, C07H 2104
Patent
active
056145055
ABSTRACT:
Homo-oligomeric 5-fluorouridine and 5-fluorodeoxyuridine (FrU.sub.n and FdU.sub.n, n=oligomer length) are synthesized and used as a polymeric drug delivery system for production of FdUMP, the potent inhibitor of thymidylate synthase (TS) and an important target in cancer chemotherapy. Disclosed are methods of both preparing and utilizing said compositions.
REFERENCES:
Marasco, et al., A Convenient Method for the Direct Incorporation of 5-Fluoro-2'-deoxycytidine into Oligodeoxynucleotides, J. of Org. Chem., vol. 57, 1992, pp. 6363-6365.
Miwa, et al., Comparative Studies on the Antitumor and Immunosuppressive Effects of the New Fluorouracil Derivative N.sup.4 -Trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and Its Parent Drug 5'-Deoxy-5-fluorouridine, Chem. Pharm. Bull., vol. 38, No. 4, pp. 998-1003, 1990.
Ouchi, et al., Synthesis and Antitumor Activity of Conjugates of 5-fluorouracil and chito-oligosaccharides Involving a Hexamethylene Spacer Group and Carbamoyl Bonds, Drug, Design and Delivery, vol. 6, pp. 281-187, 1990.
Schmidt, et al., Chemical Synthesis of 2'-deoxyoligonucleotides Containing 5-fluoro-2'-deoxycytidine, Nucleic Acids Research, vol. 20, No. 10, pp. 2421-2426, 1992.
Gmeiner William H.
Iversen Patrick L.
Kunz Gary L.
The Board of Regents of the University of Nebraska
LandOfFree
Method of treating cancer with homo-oligonuleotides of 5-FU 5'-m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating cancer with homo-oligonuleotides of 5-FU 5'-m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cancer with homo-oligonuleotides of 5-FU 5'-m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203479